TP53TG1
gene geneOn this page
Also known as H_RG012D21.9LINC00096TP53LC12
Summary
TP53TG1 (TP53 target 1, HGNC:17026) is a long non-coding RNA gene on chromosome 7q21.12.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17026 |
| Approved symbol | TP53TG1 |
| Name | TP53 target 1 |
| Location | 7q21.12 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | H_RG012D21.9, LINC00096, TP53LC12 |
| Ensembl gene | ENSG00000182165 |
| Ensembl biotype | lncRNA |
| OMIM | 616403 |
| Entrez | 11257 |
| RNAcentral | URS000075D314 — lncRNA, 751 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 63 — 63 lncRNA
ENST00000359941, ENST00000416560, ENST00000421293, ENST00000432193, ENST00000542586, ENST00000610086, ENST00000616845, ENST00000653182, ENST00000654969, ENST00000661943, ENST00000685527, ENST00000685636, ENST00000685707, ENST00000685722, ENST00000686297, ENST00000686728, ENST00000687819, ENST00000688353, ENST00000689667, ENST00000690980, ENST00000701419, ENST00000702094, ENST00000702749, ENST00000766307, ENST00000766308, ENST00000766309, ENST00000766310, ENST00000766311, ENST00000766312, ENST00000766313, ENST00000766314, ENST00000766315, ENST00000766316, ENST00000766317, ENST00000766318, ENST00000766319, ENST00000766320, ENST00000766321, ENST00000766322, ENST00000766323, ENST00000766324, ENST00000766325, ENST00000766326, ENST00000766327, ENST00000766328, ENST00000766329, ENST00000766330, ENST00000766331, ENST00000766332, ENST00000766333, ENST00000766334, ENST00000766335, ENST00000766336, ENST00000766337, ENST00000766338, ENST00000766339, ENST00000766340, ENST00000766341, ENST00000766342, ENST00000766343, ENST00000766344, ENST00000766345, ENST00000766346
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000359941 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001302559 | 87341523 | 87341684 |
| ENSE00003856441 | 87329935 | 87330094 |
| ENSE00004124954 | 87345043 | 87345540 |
| ENSE00004124968 | 87325115 | 87325444 |
Expression profiles
Bgee: expression breadth ubiquitous, 283 present calls, max score 93.59.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.9039 / max 175.2569, expressed in 1760 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 84718 | 14.8555 | 1755 |
| 84717 | 1.3685 | 671 |
| 84715 | 0.3671 | 175 |
| 84716 | 0.2059 | 94 |
| 84714 | 0.1068 | 28 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 93.59 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.16 | gold quality |
| right lobe of liver | UBERON:0001114 | 91.08 | gold quality |
| right uterine tube | UBERON:0001302 | 90.19 | gold quality |
| transverse colon | UBERON:0001157 | 90.13 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.90 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.87 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 89.83 | gold quality |
| skin of abdomen | UBERON:0001416 | 89.40 | gold quality |
| lower esophagus | UBERON:0013473 | 89.17 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 89.16 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 89.08 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 88.96 | gold quality |
| skin of leg | UBERON:0001511 | 88.91 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.83 | gold quality |
| left adrenal gland | UBERON:0001234 | 88.77 | gold quality |
| left coronary artery | UBERON:0001626 | 88.74 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 88.64 | gold quality |
| bronchus | UBERON:0002185 | 88.59 | gold quality |
| pancreatic ductal cell | CL:0002079 | 88.56 | gold quality |
| bronchial epithelial cell | CL:0002328 | 88.44 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 88.40 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.40 | gold quality |
| esophagus | UBERON:0001043 | 88.31 | gold quality |
| popliteal artery | UBERON:0002250 | 88.25 | gold quality |
| tibial artery | UBERON:0007610 | 88.23 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 88.22 | gold quality |
| adrenal cortex | UBERON:0001235 | 88.20 | gold quality |
| ascending aorta | UBERON:0001496 | 88.19 | gold quality |
| thoracic aorta | UBERON:0001515 | 88.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- From our analysis, variants in the genes ABCB4, TP53AIP1, ARHGAP32 and TMEM88B were identified linked to the alexithymia phenotype. (PMID:25882097)
- Study reports that TP53TG1 is an lncRNA that is critical for the correct response of p53 to DNA damage. The cancer growth suppressor features of TP53TG1 are linked to its ability to block the tumorigenic activity of the RNA binding protein YBX1. The DNA methylation-associated silencing of TP53TG1 produces aggressive tumors that are resistant to cellular death when DNAdamaging agents and small targeted molecules are used. (PMID:27821766)
- data showed that TP53TG1 under glucose deprivation may promote cell proliferation and migration by influencing the expression of glucose metabolism related genes in glioma. (PMID:28569381)
- TP53TG1 could directly bind to miR-96 and effectively function as a sponge for miR-96, antagonizing the functions of miR-96 and leading to derepression of KRAS, which is a core oncogene in the initiation and maintenance of pancreatic ductal adenocarcinoma (PDAC). TP53TG1 contributes to the growth and progression of PDAC by acting as a competing endogenous RNA to competitively bind to miR-96 and regulate KRAS expression. (PMID:31325400)
- Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer. (PMID:32020607)
- Long Noncoding RNA TP53TG1 Contributes to Radioresistance of Glioma Cells Via miR-524-5p/RAB5A Axis. (PMID:32762546)
- Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2. (PMID:35090377)
- Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model. (PMID:35871431)
- m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. (PMID:36114757)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.